Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease

Y. Tavil, O. Köktürk, T. Ulukavak Çiftçi, A. Kanbay, R. Yalçin (Ankara, Turkey)

Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Session: Cardiovascular consequences of obstructive sleep apnoea
Session type: Poster Discussion
Number: 4700
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Tavil, O. Köktürk, T. Ulukavak Çiftçi, A. Kanbay, R. Yalçin (Ankara, Turkey). Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease. Eur Respir J 2006; 28: Suppl. 50, 4700

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008


Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Cardiac troponin I levels and relationship with cardiovascular morbidity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005

Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007

Association of symptom subtypes and obstructive sleep apnoea-specific hypoxic burden with cardiovascular morbidity and all-cause mortality
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021


Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012


The cardiovascular  comorbidity and the risk of stroke by means of CHADS2- VASc scale  in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017


Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005


Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008

A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001


Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006

Is there a gender difference in cardiovascular mortality in obstructive sleep apnoea?
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009

Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012


Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome
Source: Eur Respir J 2015; 45: 419-427
Year: 2015



Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008


Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002